Myocarditis
C Basso - New England Journal of Medicine, 2022 - Mass Medical Soc
Myocarditis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …
[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …
Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document
Myocarditis is an inflammatory disease of the heart that may occur because of infections,
immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed …
immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed …
Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week
R Kawakami, A Sakamoto, K Kawai, A Gianatti… - Journal of the American …, 2021 - jacc.org
To investigate whether severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)–
induced myocarditis constitutes an important mechanism of cardiac injury, a review was …
induced myocarditis constitutes an important mechanism of cardiac injury, a review was …
SARS-CoV-2: a potential novel etiology of fulminant myocarditis
C Chen, Y Zhou, DW Wang - Herz, 2020 - Springer
Coronaviruses are enveloped nonsegmented positive-sense RNA viruses, which are
broadly distributed in humans and other mammals, including camels, bats, masked palm …
broadly distributed in humans and other mammals, including camels, bats, masked palm …
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
BP Halliday, R Wassall, AS Lota, Z Khalique… - The Lancet, 2019 - thelancet.com
Background Patients with dilated cardiomyopathy whose symptoms and cardiac function
have recovered often ask whether their medications can be stopped. The safety of …
have recovered often ask whether their medications can be stopped. The safety of …
[HTML][HTML] Cardiovascular complications of COVID-19
F Farshidfar, N Koleini, H Ardehali - JCI insight, 2021 - ncbi.nlm.nih.gov
The emergence of the novel SARS coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …
Epidemiology of the inherited cardiomyopathies
WJ McKenna, DP Judge - Nature Reviews Cardiology, 2021 - nature.com
In the absence of contemporary, population-based epidemiological studies, estimates of the
incidence and prevalence of the inherited cardiomyopathies have been derived from …
incidence and prevalence of the inherited cardiomyopathies have been derived from …
Multisystem inflammatory syndrome in children (MIS-C), a post-viral myocarditis and systemic vasculitis—a critical review of its pathogenesis and treatment
JC McMurray, JW May, MW Cunningham… - Frontiers in …, 2020 - frontiersin.org
MIS-C is a newly defined post-viral myocarditis and inflammatory vasculopathy of children
following COVID-19 infection. This review summarizes the literature on diagnosis …
following COVID-19 infection. This review summarizes the literature on diagnosis …
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important
cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural …
cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural …